Category: Business

Genentech’s Latest Effort to Combat Breast Cancer

South San Francisco, CA   October 16, 2018 Press Release Genentech’s Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment — Phase III KATHERINE study shows Kadcyla® significantly improved invasive…

FDA Approves Genentech’s Hemlibra

South San Francisco, CA  October 4, 2018 Press Release FDA Approves Genentech’s Hemlibra (Emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis based on an intra-patient comparison Only…